Evidence exists that some abused
solvents have
N-methyl-D-aspartic acid (
NMDA) antagonist activity, although which of their effects may be related to this mechanism is not well understood. The effects of
toluene and
1,1,1-trichloroethane (TCE) on
NMDA-induced
seizures in mice were studied using three experimental protocols: (a) animals injected i.p. with 120 or 170 mg/kg
NMDA and immediately afterwards exposed to
solvent vapors or air for 30 min (co-exposure protocol); (b) mice exposed for 30 min to
solvent or air, then injected with
NMDA and placed in the chamber for a second 30-min exposure (pre-exposure+co-exposure protocol); and (c) mice that inhaled 4000 ppm
toluene or air for 30 min twice a day, 6 h apart, for 7 days, and were injected with 120 mg/kg
NMDA immediately before a 30-min
toluene exposure (repeated exposure protocol). When given acutely,
toluene, but not TCE, produced concentration-dependent protection against
NMDA-induced
seizures. Higher concentrations of
toluene were also effective against the lethal effects produced by 170 mg/kg
NMDA. Clearer effects were seen when the pre-exposure+co-exposure protocol was followed. Under these conditions the IC(50) for
toluene was 739 ppm (653-825) against seizure occurrence and 2127 ppm (1966-2288) against lethality. Repeated exposure to
toluene did not result in tolerance to its
anticonvulsant effects. These results are consistent with the in vitro effects described for
toluene as a noncompetitive
NMDA antagonist and as a compound that enhances GABAergic transmission. The lack of protective effects of TCE is not consistent with its in vitro actions.